Comparison of Effects of Rosuvastatin (10 mg) Versus Atorvastatin (40 mg) on Rho Kinase Activity in Caucasian Men With a Previous Atherosclerotic Event by Rawlings, Ron, MD, Nohria, Anju, MD, Liu, Ping-Yen, MD, PhD, Donnelly, Jason, BA, Creager, Mark A., MD, Ganz, Peter, MD, Selwyn, Andrew, MD, Liao, James K., MD

Get full text

Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study by Lazo, Mariana, MD, PhD, ScM, Halushka, Marc K., MD, PhD, Shen, Lu, ScM, Maruthur, Nisa, MD, MHS, Rebholz, Casey M., PhD, Rawlings, Andreea M., MS, Hoogeveen, Ron C., PhD, Brinkley, Tina E., PhD, Ballantyne, Christie M., MD, Astor, Brad C., PhD, MPH, Selvin, Elizabeth, PhD, MPH

Get full text

Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events by McEvoy, John W., MB, BCh, BAO, MHS, Chen, Yuan, MS, Rawlings, Andreea, PhD, Hoogeveen, Ron C., PhD, Ballantyne, Christie M., MD, Blumenthal, Roger S., MD, Coresh, Josef, MD, PhD, Selvin, Elizabeth, MPH, PhD

Get full text